Sponsored Content | Case Study | Women's Health | July 06, 2016

Enhancing Precision, Growing Patient Volume, Fighting a Growing Public Health Threat

How the Fundacion de Cancer de Mama (FUCAM) is using the TomoTherapy System to provide critical breast cancer treatment to underserved populations

women's health, radiation oncology

The Radiation Oncology Team of FUCAM.

tomotherapy

The team of professionals at FUCAM pictured with their TomoTherapy system.

nonprofit, women's health

FUCAM, the first non-profit institution established in Mexico and in Latin America with services, equipment and highly specialized personnel fully trained on the treatment of diseases of the breast.

Following the global trend, cancer rates in Mexico continue to rise — and breast cancer is now the number-one killer of Mexican women. Unfortunately, only around half of Mexican women have access to mammography screening, and one in four women are diagnosed at advanced stages of breast cancer. Extending screening is a critical first step to reducing breast cancer deaths. But with fewer than 250 radiation oncologists for its 100 million-plus population, high patient volume is a challenge for all Mexico cancer treatment facilities. 

First-of-its-Kind Breast Cancer Treatment Center

To address the growing public health threat posed by breast cancer, in 2008 the Mexican government helped launch a new non-profit institution dedicated exclusively to breast cancer treatment. The Fundacion de Cancer de Mama (FUCAM), in Mexico City, is the first of its kind in both Mexico and throughout Latin America. FUCAM gives particular focus to reaching those most vulnerable and marginalized populations of women in Mexico, providing screening, diagnosis and a wide range of treatments for breast cancer, as well as promoting public education about the importance of early detection. 

FUCAM’s six mobile units connect with women around the country, providing screening and referring women to its central operations for treatment. This drives a huge daily patient volume at FUCAM. The center provides around 100 medical consultations, 70 mammograms, 75 breast ultrasounds, 40 surgeries and nearly 50 radiation therapy treatments every day.

Complex Cases Create Need for New Precision Treatment Solution

Because of the high percentage of late-stage diagnoses, one in five treatment cases at FUCAM are highly complex, including bilateral breast cancer and palliative cases where patients have lesions in the central nervous system, spine, pelvis and other complicated areas. “Because of this complexity, we obviously have the need for a precise system that allows us to do very detailed planning,” said Judith Huerta Bahena, M.D., head of radiotherapy, Institute of Diseases of the Breast, FUCAM.

In 2014, FUCAM began looking to invest in new radiation therapy to deliver this precise treatment capability. “We needed high-quality technology that could deliver conventional radiation therapy in addition to extreme hypo-fractionation to address a variety of patient needs,” said Huerta.

Top Priority: High-volume Efficiency

The ability to handle FUCAM’s high patient volume was a top priority. “We are a reference center for breast cancer patients, receiving about 1,000 new cases per year, so it was critical that we select a versatile and efficient radiation therapy system that yielded lower treatment planning and treatment delivery times,” said Huerta.

Patient Volume Ramps Up Quickly

FUCAM deployed the TomoTherapy System at the end of 2014. The institution immediately began leveraging the technology for treatment planning. “We were able to start treatment planning even before we had permits to begin treatment,” said Huerta. This enabled quick ramp-up of treatment volume, as FUCAM went from treating 15 patients in its first week with the TomoTherapy System up to a full schedule of 40+ patients/day by just the third week.

FUCAM uses both the TomoHelical and TomoDirect delivery modes. Parameters established by FUCAM dosimetrists define maximum doses and help define which delivery mode is optimal per patient case. “If [we] can do it with TomoDirect, that will be our first option; if not, we will use TomoHelical,” Huerta said.

As of March 2016, FUCAM was averaging treatment of 54 patients every day, and had already treated nearly 900 patients through the public system, in addition to private patients.

Efficient Planning Increases Patient Volume

The TomoTherapy System is improving clinical outcomes at FUCAM, driving patient volume. “The advantage that I see with the TomoTherapy System is that planning is very friendly, simple and fast compared to other systems,” said Huerta. This faster planning complements the TomoTherapy System’s highly efficient treatment delivery, enabling FUCAM to treat more patients in less time. Patient treatment slots at FUCAM are now just eight minutes long, with the simplest cases treated in half that time. The efficient planning and treatment delivery of the TomoTherapy System will enable FUCAM to treat nearly twice as many patients as it did before deploying the solution.

Comfortable Equipment Improves Patient Experience

The TomoTherapy System is also enhancing patient experiences at FUCAM. Huerta notes that patient positioning is easier and more comfortable with the new technology. Patients immediately recognize the comfort, and experience fewer issues with claustrophobia or other treatment anxieties. 

“Many patients still arrive with treatment anxieties, but once they see the equipment and how other patients come out of the treatment, they become excited, they get treated, and they are very satisfied,” said Huerta. In fact, since deploying the TomoTherapy System, FUCAM has not had a single patient refuse treatment based on such anxieties. Patients from other facilities are now requesting treatment at FUCAM, as word of the TomoTherapy System has spread quickly within the patient community.

A Clear Business Impact — A Satisfied Customer

The clinical and business impact of the TomoTherapy System is unmistakable for FUCAM. Huerta was confident in the potential of the TomoTherapy System to increase patient volume, but said “we are actually doing better than what we planned for.” Before installation, FUCAM was treating around 500 patients annually. The institution estimates that treatment volume will surpass 1,000 patients for 2015 — nearly doubling their previous volume and exceeding their initial goal by 50 percent.

 

Case study supplied by Accuray.

Related Content

Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles
Technology | Breast Density | January 31, 2019
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Feature | Breast Imaging | January 30, 2019 | By Jeff Zagoudis
The importance of early detection of...